AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Enristas 4 MF Tablet SR

Prescription Icon
Prescription Required

Marketer

Anthem Biopharma

Salt Composition

Glimepiride (4mg) + Metformin (500mg)

Overview Enristas 4 MF Tablet SR

DiabetaComb 4 SR tablets are antidiabetic medications combining two drugs for adult type 2 diabetes management. They help regulate blood glucose. Take DiabetaComb 4 SR with meals, consistently at the same time daily for optimal effect. Dosage is determined by your physician and may adjust based on your blood sugar response. Continue taking this medication even if feeling well or if blood sugar is controlled; abrupt cessation can elevate blood sugar, risking kidney complications, vision loss, nerve damage, and limb loss. This medication is one component of a comprehensive treatment plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify its symptoms (sweating, dizziness, headache, trembling) and how to manage them. Maintain regular meals and carry a fast-acting glucose source (sugary foods or juice). Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor of any history of heart disease before starting this medication; it may be unsuitable. Pregnant or breastfeeding individuals should consult their physician prior to use. Regular blood sugar monitoring is necessary, and your doctor might order blood tests to check blood cell counts and liver function.

Uses of Enristas 4 MF Tablet SR

Managing type 2 diabetes

Major Benefits of Enristas 4 MF Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Enristas 4 MF Tablet SR with a meal.

Common Side effects of Enristas 4 MF Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Enristas 4 MF Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Enristas 4 MF Tablet SR with a meal.

How Enristas 4 MF Tablet SR works:

Enristas 4 MF Tablet SR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Enristas 4 MF Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Enristas 4 MF Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The extended-release Enristas 4 MF Tablet is contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving may result from abnormally low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Enristas 4 MF Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Close monitoring of renal function is recommended during treatment. Consult your physician for guidance.

LiverLiverCAUTION

Patients with liver impairment should use Enristas 4 MF Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, initiation with a low Enristas 4 MF Tablet SR dose is typical; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Enristas 4 MF Tablet SR :

Should you forget a dose of Enristas 4 MF Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Enristas 4 MF Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Enristas 4 MF Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Enristas 4 MF Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Enristas 4 MF Tablet SR and seek immediate medical attention.
Enristas 4 MF Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 DM.
Enristas 4 MF Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Enristas 4 MF Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Enristas 4 MF Tablet SR can cause hypoglycemia (low blood sugar), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Enristas 4 MF Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Enristas 4 MF Tablet SR
125
MRP 145
13% off